Evidence map›Paper›PMID 19805367›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2009

Elucidating the genetic architecture of familial schizophrenia using rare copy number variant and linkage scans.

Bin Xu, Abigail Woodroffe, Laura Rodriguez-Murillo, J Louw Roos, Elizabeth J van Rensburg, Gonçalo R Abecasis, Joseph A Gogos, Maria Karayiorgou

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Effects of neuregulin 3 genotype on human prefrontal cortex physiology.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2014
    Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Two polygenic mouse models of major depressive disorders identify TMEM161B as a potential biomarker of disease in humans.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Peripheral Expression ofPsychiatry and clinical psychopharmacology · 2021
    Article
  18. Article
  19. Article
  20. Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bin XuDepartments of Psychiatry, Physiology and Cellular Biophysics, and Neuroscience, Columbia University Medical Center, New York, NY 10032.
Abigail Woodroffe
Laura Rodriguez-Murillo
J Louw Roos
Elizabeth J van Rensburg
Gonçalo R Abecasis
Joseph A Gogos
Maria Karayiorgou

Funding

MAPPING GENES FOR SCHIZOPHRENIA IN FOUNDER POPULATIONSR01MH061399 · NIMH · ROCKEFELLER UNIVERSITY · PI KARAYIORGOU, MARIA · 2000 to 2014
$7.1M
Elucidation of gene networks underlying susceptibility to schizophreniaR01MH077235 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GOGOS, JOSEPH A · 2007 to 2009
$1.3M
NIMH NIH HHS MH061399NIMH NIH HHS MH077235NIMH NIH HHS R01 MH061399NIMH NIH HHS R01 MH077235
6 · The paper itself

Abstract

To elucidate the genetic architecture of familial schizophrenia we combine linkage analysis with studies of fine-level chromosomal variation in families recruited from the Afrikaner population in South Africa. We demonstrate that individually rare inherited copy number variants (CNVs) are more frequent in cases with familial schizophrenia as compared to unaffected controls and affect almost exclusively genic regions. Interestingly, we find that while the prevalence of rare structural variants is similar in familial and sporadic cases, the type of variants is markedly different. In addition, using a high-density linkage scan with a panel of nearly 2,000 markers, we identify a region on chromosome 13q34 that shows genome-wide significant linkage to schizophrenia and show that in the families not linked to this locus, there is evidence for linkage to chromosome 1p36. No causative CNVs were identified in either locus. Overall, our results from approaches designed to detect risk variants with relatively low frequency and high penetrance in a well-defined and relatively homogeneous population, provide strong empirical evidence supporting the notion that multiple genetic variants, including individually rare ones, that affect many different genes contribute to the genetic risk of familial schizophrenia. They also highlight differences in the genetic architecture of the familial and sporadic forms of the disease.

Indexed as

Gene DosageGenetic LinkageGenetic VariationCohort StudiesGenome, HumanHumansSchizophreniaSouth Africa

Identifiers

PMID19805367
PMCPMC2757863

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.